These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 34698843
1. Total Dystrophic Onychomycosis Successfully Treated with Efinaconazole Topical Solution in Times of Coronavirus Disease of 2019: A Case Study. Garoufalis MG. J Am Podiatr Med Assoc; 2022 Apr 27; 112(2):. PubMed ID: 34698843 [Abstract] [Full Text] [Related]
2. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis. Pollak RA. J Am Podiatr Med Assoc; 2014 Nov 27; 104(6):568-73. PubMed ID: 25514267 [Abstract] [Full Text] [Related]
3. Topical treatment of onychomycosis with efinaconazole solution 10%. Rich P. Cutis; 2013 Jun 27; 91(6):305-7. PubMed ID: 23837154 [Abstract] [Full Text] [Related]
4. Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients. Eichenfield LF, Elewski B, Sugarman JL, Rosen T, Vlahovic TC, Gupta AK, Stein Gold L, Pillai R, Guenin E. J Drugs Dermatol; 2020 Sep 01; 19(9):867-872. PubMed ID: 33026753 [Abstract] [Full Text] [Related]
5. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail. Lipner SR, Scher RK. Expert Rev Clin Pharmacol; 2015 Sep 01; 8(6):719-31. PubMed ID: 26325488 [Abstract] [Full Text] [Related]
6. Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis. Tosti A. Cutis; 2013 Oct 01; 92(4):203-8. PubMed ID: 24195094 [Abstract] [Full Text] [Related]
7. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. Gupta AK, Fleckman P, Baran R. J Am Acad Dermatol; 2000 Oct 01; 43(4 Suppl):S70-80. PubMed ID: 11051136 [Abstract] [Full Text] [Related]
8. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails. Sakamoto M, Sugimoto N, Kawabata H, Yamakawa E, Kodera N, Pillai R, Tatsumi Y. J Drugs Dermatol; 2014 Nov 01; 13(11):1388-92. PubMed ID: 25607707 [Abstract] [Full Text] [Related]
9. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis? Elewski BE, Cantrell W, Lin T. J Drugs Dermatol; 2018 Feb 01; 17(2):175-178. PubMed ID: 29462225 [Abstract] [Full Text] [Related]
10. Labeled use of efinaconazole topical solution 10% in treating onychomycosis in children and a review of the management of pediatric onychomycosis. Gupta AK, Venkataraman M, Shear NH, Piguet V. Dermatol Ther; 2020 Jul 01; 33(4):e13613. PubMed ID: 32418289 [Abstract] [Full Text] [Related]
11. Efinaconazole solution 10% for treatment of toenail onychomycosis in Latino patients. Cook-Bolden FE, Lin T. Cutis; 2017 Apr 01; 99(4):286-289. PubMed ID: 28492600 [Abstract] [Full Text] [Related]
12. Prognostic Factors for Complete Cure Following Treatment of Mild and Moderate Toenail Onychomycosis With Efinaconazole Topical Solution 10. Jellinek NJ, Korotzer A. J Drugs Dermatol; 2015 Aug 01; 14(8):871-5. PubMed ID: 26267732 [Abstract] [Full Text] [Related]
13. Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early. Rich P. J Drugs Dermatol; 2015 Jan 01; 14(1):58-62. PubMed ID: 25607909 [Abstract] [Full Text] [Related]
14. Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution. Cantrell W, Canavan T, Elewski B. J Drugs Dermatol; 2015 May 01; 14(5):524-6. PubMed ID: 25942674 [Abstract] [Full Text] [Related]
15. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies. Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H, Ieda C, Smith K, Pillai R, Ramakrishna T, Olin JT. J Am Acad Dermatol; 2013 Apr 01; 68(4):600-608. PubMed ID: 23177180 [Abstract] [Full Text] [Related]
16. Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes. Vlahovic TC, Joseph WS. J Drugs Dermatol; 2014 Oct 01; 13(10):1186-90. PubMed ID: 25607552 [Abstract] [Full Text] [Related]
17. Topical efinaconazole: A promising therapeutic medication for tinea unguium. Noguchi H, Matsumoto T, Hiruma M, Asao K, Hirose M, Fukushima S, Ihn H. J Dermatol; 2018 Oct 01; 45(10):1225-1228. PubMed ID: 30035311 [Abstract] [Full Text] [Related]
18. Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim Analysis. Gupta AK, Cooper EA. Skin Therapy Lett; 2021 Jan 01; 26(1):5-10. PubMed ID: 33539062 [Abstract] [Full Text] [Related]
19. Topical treatment of onychomycosis as a realistic option to systemic therapy: a case report. Gupta AK. J Am Podiatr Med Assoc; 2014 Jan 01; 104(1):115-7. PubMed ID: 24504588 [Abstract] [Full Text] [Related]
20. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study. Shemer A, Nathansohn N, Trau H, Amichai B, Grunwald MH. J Dermatol; 2010 Feb 01; 37(2):137-9. PubMed ID: 20175847 [Abstract] [Full Text] [Related] Page: [Next] [New Search]